Compare StocksAVGO vs HCA

Broadcom Inc. (AVGO) vs HCA Healthcare, Inc. (HCA): Which Is the Better Buy in 2026?

As of 2026-06-19, AVGO is overvalued at $411, with a DCF intrinsic value of $258 and a margin of safety of -59%. HCA is undervalued at $375, with an intrinsic value of $523 and a margin of safety of 28%. Of the two, HCA has the wider margin of safety.

AVGO
Broadcom Inc.
$411.35
VS
HCA
HCA Healthcare, Inc.
$375.17

Rewards

AVGO
  • Gross margin of 76.3% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Free cash flow has grown at a 18.2% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $11.66 of earning power — management is an exceptional capital allocator.
HCA
  • HCA Healthcare, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • HCA Healthcare, Inc. scores 95/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • Free cash flow has grown at a 23.1% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

AVGO
  • ROIC has declined by 6.5 percentage points over the past 4 years, which may signal competitive erosion.
  • Share count has increased by 13% over the past 4 years, diluting existing shareholders.
  • FCF yield of 1.4% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
HCA

    Key Valuation Metrics

    Learn more →
    AVGO
    HCA
    Valuation
    $27.21B
    Free Cash Flow
    $7.69B
    1.39%
    FCF Yield
    9.24%
    68.22
    Trailing P/E
    12.93
    21.26
    Forward P/E
    11.33
    Quality & Moat
    19.14%
    ROIC
    18.14%
    37.28%
    ROE
    N/A
    76.28%
    Gross Margin
    41.61%
    0.68
    PEG Ratio
    1.20
    Balance Sheet Safety
    0.52
    Net Debt / Equity
    N/A
    N/A
    Interest Coverage
    N/A
    1.08
    Net Debt / EBITDA
    3.13
    0.69%
    Dividend Yield
    0.76%
    AVGO: 5Ties: 1HCA: 4
    AVGOHCA

    Historical Fundamentals

    Learn more →
    AVGO

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    HCA

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    AVGO
    $97.03
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $14.50B
    Δ Market Cap
    +$1.41T
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    HCA
    $2.43
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $15.76B
    Δ Market Cap
    +$38.30B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    AVGO
    16.0% Margin of Safety
    Price is 16.0% below estimated fair value
    Current Price: $411.35
    Fair Value: $489.83
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    HCA
    28.2% Margin of Safety
    Price is 28.2% below estimated fair value
    Current Price: $375.17
    Fair Value: $522.55
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    AVGO

    What growth rate is the market pricing in at $411?

    +23.6%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +25.6%

    The market implies +23.6% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +25.6%, reflecting heavy growth investment.

    HCA

    What growth rate is the market pricing in at $375?

    +7.3%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +5.6%

    The market implies +7.3% Owner Earnings growth, roughly in line with history — reasonably priced.

    Standard FCF implies +5.6%, reflecting ongoing growth investment.

    Economic Moat Score

    Learn more →
    AVGO
    61/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with reinvestment efficiency as the key competitive advantage. Improving revenue predictability would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    HCA
    95/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

    Forensic Accounting

    Learn more →
    AVGO
    -2.09
    Possible Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    HCA
    -2.78
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    AVGO
    Insiders 1.9%Institutions 79.9%Retail & Other 18.1%
    No. of Institutional Holders6,094
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    HCA
    Insiders 16.2%Institutions 78.3%Retail & Other 5.5%
    No. of Institutional Holders1,952
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    AVGO
    0
    Buys (3M)
    2
    Buys (12M)
    Total value (12M): $1.55M
    YOU HARRY L
    Director
    $325,129
    @ $325.13 · 2025-12-18
    YOU HARRY L
    Director
    $1.23M
    @ $345.88 · 2025-09-10
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    HCA
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    AVGO
    4
    Sells (3M)
    29
    Sells (12M)
    Total value (12M): $241.47M
    VELAGA S. RAM
    Officer
    $2.96M
    @ $370.52 · 2026-04-10
    VELAGA S. RAM
    Officer
    $10.64M
    @ $352.08 · 2026-04-09
    DELLY GAYLA J
    Director
    $358,310
    @ $358.31 · 2026-04-09
    PAGE JUSTINE F.
    Director
    $712,354
    @ $353.00 · 2026-04-08
    SPEARS KIRSTEN MARGRETA
    Chief Financial Officer
    $19.45M
    @ $323.38 · 2026-03-17
    VELAGA S. RAM
    Officer
    $20.82M
    @ $323.38 · 2026-03-17
    BRAZEAL MARK DAVID
    Officer
    $27.06M
    @ $323.39 · 2026-03-17
    KAWWAS CHARLIE B
    Officer
    $20.97M
    @ $323.39 · 2026-03-17
    BRAZEAL MARK DAVID
    Officer
    $10.41M
    @ $347.12 · 2026-01-06
    TAN HOCK E
    Chief Executive Officer
    $24.31M
    @ $347.30 · 2026-01-06
    SPEARS KIRSTEN MARGRETA
    Chief Financial Officer
    $10.43M
    @ $347.82 · 2025-12-31
    BRAZEAL MARK DAVID
    Officer
    $9.13M
    @ $352.07 · 2025-12-26
    SPEARS KIRSTEN MARGRETA
    Chief Financial Officer
    $2.03M
    @ $332.91 · 2025-12-17
    BRAZEAL MARK DAVID
    Officer
    $12.54M
    @ $327.65 · 2025-12-17
    KAWWAS CHARLIE B
    Officer
    $1.05M
    @ $332.95 · 2025-12-17
    BRAZEAL MARK DAVID
    Officer
    $8.36M
    @ $340.91 · 2025-12-16
    PAGE JUSTINE F.
    Director
    $289,512
    @ $361.89 · 2025-12-15
    PAGE JUSTINE F.
    Director
    $264,912
    @ $331.14 · 2025-11-14
    PAGE JUSTINE F.
    Director
    $280,120
    @ $350.15 · 2025-10-14
    BRAZEAL MARK DAVID
    Officer
    $9.59M
    @ $352.61 · 2025-09-17
    KAWWAS CHARLIE B
    Officer
    $2.26M
    @ $352.74 · 2025-09-17
    PAGE JUSTINE F.
    Director
    $288,000
    @ $360.00 · 2025-09-15
    PAGE JUSTINE F.
    Director
    $245,968
    @ $307.46 · 2025-08-14
    PAGE JUSTINE F.
    Director
    $219,440
    @ $274.30 · 2025-07-14
    TAN HOCK E
    Chief Executive Officer
    $10.73M
    @ $268.29 · 2025-06-26
    DELLY GAYLA J
    Director
    $795,390
    @ $265.13 · 2025-06-26
    SPEARS KIRSTEN MARGRETA
    Chief Financial Officer
    $9.50M
    @ $261.27 · 2025-06-24
    BRAZEAL MARK DAVID
    Officer
    $13.11M
    @ $262.10 · 2025-06-24
    BRAZEAL MARK DAVID
    Officer
    $12.66M
    @ $253.28 · 2025-06-23
    SPEARS KIRSTEN MARGRETA
    Chief Financial Officer
    $14.18M
    @ $251.75 · 2025-06-18
    PAGE JUSTINE F.
    Director
    $200,280
    @ $250.35 · 2025-06-16
    PAGE JUSTINE F.
    Director
    $184,152
    @ $230.19 · 2025-05-14
    PAGE JUSTINE F.
    Director
    $148,000
    @ $185.00 · 2025-04-14
    BRAZEAL MARK DAVID
    Officer
    $5.84M
    @ $194.65 · 2025-03-24
    LOW CHECK KIAN
    Director
    $11.30M
    @ $235.35 · 2025-01-06
    BRAZEAL MARK DAVID
    Officer
    $4.82M
    @ $238.79 · 2024-12-24
    TAN HOCK E
    Chief Executive Officer
    $10.80M
    @ $239.96 · 2024-12-24
    BRYANT DIANE M
    Director
    $3.40M
    @ $226.68 · 2024-12-23
    SPEARS KIRSTEN MARGRETA
    Chief Financial Officer
    $2.89M
    @ $229.62 · 2024-12-20
    YOU HARRY L
    Director
    $1.57M
    @ $240.00 · 2024-12-17
    BRAZEAL MARK DAVID
    Officer
    $3.43M
    @ $181.45 · 2024-10-11
    BRAZEAL MARK DAVID
    Officer
    $3.46M
    @ $182.88 · 2024-10-09
    BRAZEAL MARK DAVID
    Officer
    $3.59M
    @ $177.10 · 2024-10-07
    DELLY GAYLA J
    Director
    $130,898
    @ $174.53 · 2024-09-25
    PAGE JUSTINE F.
    Director
    $444,566
    @ $1750.26 · 2024-06-20
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    HCA
    0
    Sells (3M)
    7
    Sells (12M)
    Total value (12M): $32.73M
    MCALEVEY MICHAEL R.
    Officer
    $903,537
    @ $533.37 · 2026-02-18
    WYATT CHRISTOPHER F
    Officer
    $2.02M
    @ $505.00 · 2026-02-11
    BERRES JENNIFER
    Officer
    $4.13M
    @ $514.58 · 2026-02-11
    HAZEN SAMUEL N
    Chief Executive Officer
    $21.48M
    @ $501.04 · 2026-02-03
    CUFFE MICHAEL S
    Officer
    $747,135
    @ $498.09 · 2026-02-03
    MCALEVEY MICHAEL R.
    Officer
    $1.84M
    @ $473.79 · 2025-11-05
    CUFFE MICHAEL S
    Officer
    $1.61M
    @ $418.84 · 2025-09-08
    FOSTER JON MARK
    Officer
    $5.80M
    @ $369.32 · 2025-05-13
    BERRES JENNIFER
    Officer
    $3.08M
    @ $322.59 · 2025-02-14
    BILLINGTON PHILLIP G
    Officer
    $1.36M
    @ $350.00 · 2024-11-14
    WHALEN KATHLEEN M
    Officer
    $527,677
    @ $357.99 · 2024-11-14
    AKDAMAR EROL R
    Officer
    $1.02M
    @ $353.00 · 2024-11-14
    CUFFE MICHAEL S
    Officer
    $3.22M
    @ $385.42 · 2024-09-12
    WHALEN KATHLEEN M
    Officer
    $1.76M
    @ $362.13 · 2024-07-31
    WYATT CHRISTOPHER F
    Officer
    $1.44M
    @ $360.20 · 2024-07-29
    REINER DEBORAH M
    Officer
    $1.19M
    @ $359.96 · 2024-07-29
    TORRES KATHRYN A
    Officer
    $659,328
    @ $355.05 · 2024-07-25
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    AVGO
    FearGreed
    😐Neutral(49/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    HCA
    FearGreed
    😨Fear(39/100)

    "Market is pessimistic — investigate whether fears are temporary or structural"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    AVGO
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
    HCA
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Fear (39)
    View AVGO Full AnalysisView HCA Full Analysis

    Frequently Asked Questions: AVGO vs HCA

    Is Broadcom Inc. or HCA Healthcare, Inc. more undervalued in 2026?

    Based on our discounted cash flow model, HCA trades at a 28.2% margin of safety (intrinsic value $523 vs. price $375), compared to AVGO's -59.4% margin of safety (intrinsic $258 vs. $411).

    Which stock has a wider economic moat, Broadcom Inc. or HCA Healthcare, Inc.?

    HCA scores 95/100 (Wide moat), while AVGO scores 61/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is HCA Healthcare, Inc. in financial distress?

    HCA's Altman Z-Score of 2.7 places it in the Grey zone, signaling elevated bankruptcy risk. AVGO scores 12.0 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which company has better free cash flow, Broadcom Inc. or HCA Healthcare, Inc.?

    HCA Healthcare, Inc. (HCA) generates a 9.2% free cash flow yield, compared to Broadcom Inc.'s 1.4%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, Broadcom Inc. or HCA Healthcare, Inc.?

    AVGO earns 19.1% ROIC versus HCA's 18.1%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, Broadcom Inc.'s or HCA Healthcare, Inc.'s?

    HCA's dividend earns a safety score of 94/100 (Very Safe), compared to AVGO's 94/100 (Very Safe). HCA has raised its dividend for 3 consecutive years.